drugset / Trial / NCT02742441

A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis (Study 310)

NCT02742441

Phase 3 Completed 409 enrolled Therapeutics, Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This Phase 3 study (Study 310) has been designed to determine and compare the efficacy and safety of 122-0551 Foam and Vehicle Foam applied twice daily for two weeks in subjects with plaque psoriasis.

Timeline

Start
2016-06
Primary completion
2017-02-27
Completion
2017-06-16

Drugs

EvaluationDrugModalityDoseRoute
Subject halobetasol propionate Small molecule 0.05 % Topical

Indications